Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,810 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

Financing Strategies of Influenza Vaccination in China

NCT04038333

Conditions: Behavior, Cost of Illness, Health Knowledge, Attitudes, Practice, +9 more
Locations: Peking University Health Science Center Beijing, Beijing Municipality, China

Shandong University Jinan, Shandong, China

Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure

NCT02787044

Conditions: Cardiovascular Diseases, Heart Diseases, Heart Failure, +15 more
Locations: Birmingham VAMC Birmingham, Alabama, United States

University of Alabama Hypertension Program Birmingham, Alabama, United States

Heart Center Research, LLC Huntsville, Alabama, United States

Alaska Heart & Vascular Institute Anchorage, Alaska, United States

View all 190 locations

View Trial Details

Completed

Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness

NCT04570904

Conditions: Infections, Influenza, Influenza -Like Illness, +6 more
Locations: Leicester Royal Infirmary Leicester, Leicestershire, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

NCT04074928

Conditions: Human, Infections, Influenza, +6 more
Locations: 84035 CCR Research Mobile, Alabama, United States

84040 Southland Clnical Research Center Anaheim, California, United States

84044 Premier Health Research Center Downey, California, United States

84028 Orange County Research Institute Ontario, California, United States

View all 47 locations

View Trial Details

Completed

The Objectives of This Study Are Study the Immunogenicity and Safety of the Flu-M [Inactivated Split Influenza Vaccine], vs. the Ultrix® Inactivated Split Influenza Vaccine, in Volunteers Who Are Over 60 Years Old

NCT05089123

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: LLC "Meditsinskie Tehnologii" Saint Petersburg, Russia

LLC "Strategicheskie Meditsinskie Sistemi" Saint Petersburg, Russia

View Trial Details

Completed

The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years

NCT05126979

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Perm State Medical University named after academician E.A. Wagner Perm, Russia

View Trial Details

Completed

The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers

NCT05152017

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Federally Funded Healthcare Institution Primary Healthcare Unit No. 163 Novosibirsk, Russia

View Trial Details

Completed

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

NCT04110366

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: Imperial Clinical Respiratory Research Unit London, United Kingdom

View Trial Details

Completed

Comparison of Three Licensed Influenza Vaccines

NCT03068949

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: University of Rochester Medical Center, Vaccine Research Unit Room 3-5000 Rochester, New York, United States

View Trial Details

Completed

Patient Portal - Flu Reminder Recall

NCT03666026

Conditions: Infections, Influenza, Influenza, Human, +6 more
Locations: University of California, Los Angeles Los Angeles, California, United States

View Trial Details

Orthomyxoviridae Infections

Orthomyxoviridae Infections trial results

Related conditions